Dose reduction, slower titration, medication timing adjustments, or temporary discontinuation may be needed
Additionally, findings suggested that DA transporter availability was lower in the exenatide group compared to the placebo group, potentially indicating altered DA dynamics associated with reduced cravings and cue sensitivity (Zhang et al., 2019)
The evidence is pretty clear on this: a lot of patients regain weight when they come off GLP-1 therapy
Advice: If using omeprazole long-term, it is advisable to monitor B12 levels, and vitamin B12 supplementation (oral or injection) may be needed after consulting your doctor
Schmieder RE, Ott C, Schmid A, Friedrich S, Kistner I, Ditting T, et al
BPC 157 to wietna metoda na zwikszenie przepywu natlenionej krwi do uszkodzonych tkanek